HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antiseptic TFM performance criteria too stringent, industry rep tells FDA advisory cmte.

This article was originally published in The Rose Sheet

Executive Summary

ANTISEPTIC TFM PERFORMANCE CRITERIA TOO STRINGENT, INDUSTRY REP CLAIMS at a meeting of FDA's Nonprescription Drugs Advisory Committee in Bethesda, Md. July 29. Rhonda Jones, Scientific & Regulatory Consultants, Inc., presented five examples of antiseptic formulations used in consumer and health care environments that she said "fall short of the current performance criteria proposed" in FDA's 1994 health care antiseptic tentative final monograph. Two triclosan hand wash formulations, 1% and .3% -- which are often found in consumer products -- do not meet TFM performance criteria, despite having "positive clinical outcomes" and the potential for "viral removal" in other studies, Jones maintained.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005657

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel